Pmv Pharmaceuticals Inc (PMVP)

Finanzdaten der Pmv Pharmaceuticals Inc-Aktie (PMVP)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	6.76% 2.952	3.166	2.984	2.696	2.325
Operating Expenses	3.60% 18.22	18.90	19.63	20.12	21.48
Benefits Costs and Expenses	3.70% 18.22	18.92	19.62	20.13	21.45
Costs And Expenses	3.70% 18.22	18.92	19.62	20.13	21.45
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	3.60% -18.22	-18.90	-19.63	-20.12	-21.48
Net Interest Income/Expense	6.76% 2.952	3.166	2.984	2.696	2.325
Interest Income/Expense After Provision For Losses	6.76% 2.952	3.166	2.984	2.696	2.325
Income/Loss From Continuing Operations Before Tax	3.09% -15.27	-15.76	-16.64	-17.43	-19.13
Income/Loss From Continuing Operations After Tax	3.08% -15.27	-15.76	-16.64	-17.44	-19.13
Net Income/Loss	3.08% -15.27	-15.76	-16.64	-17.44	-19.13
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	4,474% 51.45	1.1247	49.05	45.81	45.77
Diluted Average Shares	4,474% 51.45	1.1247	49.05	45.81	45.77
Basic Earnings Per Share	3.23% -0.30	-0.31	-0.34	-0.38	-0.42
Diluted Earnings Per Share	3.23% -0.30	-0.31	-0.34	-0.38	-0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-